<DOC>
	<DOCNO>NCT01164488</DOCNO>
	<brief_summary>This non-randomized , open-label study evaluate interaction RO5190591 ( danoprevir ) /ritonavir without ketoconazole safety tolerability healthy volunteer . Participants administer repeated daily dos ketoconazole alone , RO5190591/ritonavir , RO5190591/ritonavir plus ketoconazole . The anticipated time study treatment 25 day .</brief_summary>
	<brief_title>A Study RO5190591 ( Danoprevir ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Adult healthy volunteer , age 1864 year , inclusively Weight &gt; /=50.0 kg Body Mass Index ( BMI ) 18.032.0 kg/m2 Ability willingness abstain alcohol , xanthinecontaining beverage food ( coffee , tea , cola , chocolate , `` energy drink '' ) 48 hour prior entry clinical study center discharge Ability willingness abstain grapefruit grapefruit juice , star fruit , Seville oranges 7 day prior entry clinical study center discharge Medical history without major recent ongoing pathology Pregnant lactate woman male partner woman pregnant lactating Sustained supine systolic blood pressure &gt; 140 &lt; 90 mmHG supine diastolic blood pressure &gt; 90 &lt; 50 mmHG Screening Day 1 Resting heart rate &gt; 100 &lt; 45 beat per minute Screening Day 1 Any history clinically significant cardiovascular cerebrovascular disease Positive drug test result screen admission Donation loss blood 450 ml ( 1 pint ) within 60 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>